Inhibition of type II phospholipase A(2) by LY329722 attenuates ischemia and reperfusion injury of canine livers.
Ogata
K
K
First Department of Surgery, Hokkaido University, School of Medicine, Sapporo, Japan.
Jin
M B
MB
Suzuki
T
T
Taniguchi
M
M
Shimamura
T
T
Fukai
M
M
Furukawa
H
H
Todo
S
S
D000085:Acetates / Q000627:therapeutic use*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D054501:Group II Phospholipases A2; D007211:Indoles / Q000627:therapeutic use*; D008099:Liver / Q000098:blood supply*; D010741:Phospholipases A / Q000037:antagonists & inhibitors*; D015427:Reperfusion Injury / Q000517:prevention & control*; D013599:Systole
D000085:Acetates; D004791:Enzyme Inhibitors; D007211:Indoles; C428265:LY 329722; D010741:Phospholipases A; D054501:Group II Phospholipases A2